Last $2.36 USD
Change Today -0.11 / -4.45%
Volume 78.2K
As of 8:10 PM 08/21/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Gerhard N. Mayr

Special Advisor to the Board, Codexis, Inc.
AgeTotal Calculated CompensationThis person is connected to 43 board members in 6 different organizations across 12 different industries.

See Board Relationships
68--

Background*

Prof. Dr. Gerhard N. Mayr has been a Special Advisor of Board of Codexis, Inc. since July 2004. Dr. Mayr serves as the Head of Stability Control - Goa at Ratiopharm India Private Limited. Prof. Dr. Mayr served as an Executive Vice President of Pharmaceutical Operations at Eli Lilly & Co. from October 1999 to March 1, 2004 and was responsible for pharmaceutical operations worldwide and sales and marketing globally. Prof. Dr. Mayr joined Eli Lilly International Corporation, ...

Read Full Background

Corporate Headquarters*

200 Penobscot Drive
Redwood City, California 94063

United States

Phone: 650-421-8100
Fax: --

Board Members Memberships*

Special Advisor to the Board
Director
Director
2005-Present
Chairman of the Board, Member of Audit Committee and Member of Governance, Nomination & Compensation Committee
2006-2013
Former Director and Member of Audit & Compliance Committee
2007-2009
Former Director, Chairman of Nominating & Corporate Governance Committee, Member of Compensation Committee and Member of Audit Committee
2009-Present
Director
2012-Present
Independent External Director and Member of Audit Committee

Education*

MBA 1972
The Leland Stanford Junior University
Master's Degree 1969
Eidgenössische Technische Hochschule Zürich

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CDXS:US $2.36 USD -0.11

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Steven M. Klosk Chief Executive Officer, President and Director
Cambrex Corporation.
$533.3K
Feike Sijbesma Chairman of Managing Board, Chief Executive Officer and Chairman of DSM Nutritional Products
Koninklijke DSM N.V.
€1.4M
Satoshi Masumura Chief Executive Officer, President and Director
Takasago International Corporation
--
Peder Holk Nielsen Chief Executive Officer and President
Novozymes A/S
kr8.3M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CODEXIS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.